William Blair Comments on Prestige Consumer Healthcare Inc.’s Q2 2025 Earnings (NYSE:PBH)

Prestige Consumer Healthcare Inc. (NYSE:PBH) – Equities research analysts at William Blair lowered their Q2 2025 earnings per share estimates for shares of Prestige Consumer Healthcare in a report released on Thursday, August 8th. William Blair analyst J. Andersen now forecasts that the company will earn $1.08 per share for the quarter, down from their previous estimate of $1.09. The consensus estimate for Prestige Consumer Healthcare’s current full-year earnings is $4.42 per share. William Blair also issued estimates for Prestige Consumer Healthcare’s Q3 2025 earnings at $1.21 EPS, Q4 2025 earnings at $1.24 EPS and FY2026 earnings at $4.72 EPS.

Several other equities research analysts have also commented on the company. StockNews.com lowered Prestige Consumer Healthcare from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, May 21st. Canaccord Genuity Group restated a “buy” rating and issued a $80.00 price objective on shares of Prestige Consumer Healthcare in a research report on Tuesday, May 21st. Finally, DA Davidson reaffirmed a “buy” rating and set a $93.00 target price on shares of Prestige Consumer Healthcare in a research note on Friday, August 9th. One analyst has rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $98.25.

Prestige Consumer Healthcare Trading Up 3.1 %

Prestige Consumer Healthcare stock opened at $67.28 on Monday. The company has a current ratio of 3.20, a quick ratio of 2.02 and a debt-to-equity ratio of 0.68. Prestige Consumer Healthcare has a 12 month low of $56.34 and a 12 month high of $75.31. The stock’s 50 day simple moving average is $68.29 and its two-hundred day simple moving average is $68.66. The firm has a market cap of $3.34 billion, a PE ratio of 16.13, a P/E/G ratio of 1.93 and a beta of 0.49.

Prestige Consumer Healthcare (NYSE:PBH) last released its quarterly earnings data on Thursday, August 8th. The company reported $0.90 EPS for the quarter, topping the consensus estimate of $0.86 by $0.04. Prestige Consumer Healthcare had a return on equity of 13.48% and a net margin of 18.60%. The business had revenue of $267.10 million for the quarter, compared to analyst estimates of $260.54 million. During the same quarter in the prior year, the firm posted $1.06 EPS. The business’s quarterly revenue was down 4.4% compared to the same quarter last year.

Institutional Inflows and Outflows

Large investors have recently made changes to their positions in the business. GAMMA Investing LLC acquired a new position in shares of Prestige Consumer Healthcare during the 4th quarter worth approximately $25,000. Opal Wealth Advisors LLC acquired a new position in Prestige Consumer Healthcare in the 2nd quarter valued at $26,000. Principal Securities Inc. acquired a new position in Prestige Consumer Healthcare in the 4th quarter valued at $29,000. Quest Partners LLC raised its stake in Prestige Consumer Healthcare by 2,826.7% in the 2nd quarter. Quest Partners LLC now owns 439 shares of the company’s stock valued at $30,000 after purchasing an additional 424 shares during the last quarter. Finally, EverSource Wealth Advisors LLC raised its stake in Prestige Consumer Healthcare by 80.6% in the 1st quarter. EverSource Wealth Advisors LLC now owns 466 shares of the company’s stock valued at $33,000 after purchasing an additional 208 shares during the last quarter. 99.95% of the stock is owned by institutional investors and hedge funds.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.